Abiopharma

COMERA LIFE SCIENCES HOLDINGS, INC. (CMRA)

Symbol	CMRA
Name	COMERA LIFE SCIENCES HOLDINGS, INC.
Sector	UNDEFINED
Region	North America
Industry	-
Address	01801 United States MA 12 Gill Street Suite 4650
Telephone	(617) 871-2101
Fax	—
Email	—
Website	https://comeralifesciences.com/
Incorporation	US
Incorporated On	2022
Employees	—
Fiscal Year	12/31
Public Since	—
Exchanges	OTC
Auditor	Baker Tilly US, LLP;
Audit Status	AUDITED
Reporting Status	U.S. Reporting: SEC Reporting
CIK	0001907685
Description	Comera is a pre-clinical biotechnology company dedicated to promoting a compassionate new era in medicine. The Company applies a deep knowledge of formulation science and technology to transform essential biologic medicines from intravenous (“IV”) to subcutaneous (“SQ”) forms. This revolutionary technology provides patients and families with the freedom of self-injectable care, allowing them to realize the potential of these life changing therapies, and to unlock the vast potential of their own lives. To accomplish this, Comera is developing an internal portfolio of proprietary therapeutics that incorporate Comera’s innovative proprietary formulation platform, SQore™. Comera also collaborates with pharmaceutical and biotechnology companies, applying the SQore™ platform to Comera’s partners’ biologic medicines to deliver enhanced formulations that facilitate self-injectable care. Additional info from OTC: Comera is a pre-clinical biotechnology company dedicated to promoting a compassionate new era in medicine. The Company applies a deep knowledge of formulation science and technology to transform essential biologic medicines from intravenous (“IV”) to subcutaneous (“SQ”) forms. This revolutionary technology provides patients and families with the freedom of self-injectable care, allowing them to realize the potential of these life changing therapies, and to unlock the vast potential of their own lives. To accomplish this, Comera is developing an internal portfolio of proprietary therapeutics that incorporate Comera’s innovative proprietary formulation platform, SQore™. Comera also collaborates with pharmaceutical and biotechnology companies, applying the SQore™ platform to Comera’s partners’ biologic medicines to deliver enhanced formulations that facilitate self-injectable care.

2024-08-28 06:26

Expert Market symbol attribute type Security_Name was changed. Previous value: -. New value: COMERA LIFE SCIENCES WTS.

2024-08-28 06:25

Expert Market symbol attribute type Security_Name was changed. Previous value: -. New value: COMERA LIFE SCIENCES HLDG.

2024-08-27 08:16

OTCQX U.S. Premier symbol attribute type Security_Name was changed. Previous value: CONSUMERS BANCORP INC. New value: COMERA LIFE SCIENCES HLDG.

2024-08-27 08:14

OTCQX U.S. Premier symbol attribute type Security_Name was changed. Previous value: CONSUMERS BANCORP INC. New value: COMERA LIFE SCIENCES WTS.

2024-04-26 10:43

OTCQB symbol attribute type Security_Name was changed. Previous value: -. New value: COMERA LIFE SCIENCES HLDG.

2024-02-26 21:38

New Form S-8 POS - Comera Life Sciences Holdings, Inc. Filed: 2024-02-26 AccNo: 0000950170-24-020219 Size: 95 KB

2024-02-26 21:36

New Form S-8 POS - Comera Life Sciences Holdings, Inc. Filed: 2024-02-26 AccNo: 0000950170-24-020214 Size: 95 KB

2024-02-26 21:35

New Form POS AM - Comera Life Sciences Holdings, Inc. Filed: 2024-02-26 AccNo: 0000950170-24-020208 Size: 104 KB

2024-02-26 21:32

New Form POS AM - Comera Life Sciences Holdings, Inc. Filed: 2024-02-26 AccNo: 0000950170-24-020200 Size: 104 KB

2024-02-15 13:54

New Form 25-NSE - Comera Life Sciences Holdings, Inc. Filed: 2024-02-15 AccNo: 0001354457-24-000079 Size: 4 KB